Relationship between expression level of P-glycoprotein and daunorubicin transport in LLC-PK1 cells transfected with human MDR1 gene

Biochemical Pharmacology

Volumn 53, Issue 5, 1997, Pages 741-746

  Tanaka, Kumiko ^a   Hirai, Midori ^a,b   Tanigawara, Yusuke ^a,c   Ueda, Kazumitsu ^d   Takano, Mikihisa ^a   Hori, Ryohei ^a,e   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^c KOBE UNIVERSITY HOSPITAL   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e KINKI UNIVERSITY   (Japan)

Author keywords

cyclosporin A; daunorubicin; multidrug resistance; P glycoprotein; transcellular transport

Indexed keywords

COLCHICINE; CYCLOSPORIN A; DAUNORUBICIN; GLYCOPROTEIN P; VINBLASTINE;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOCHEMISTRY; DRUG RESISTANCE; DRUG TRANSPORT; GENE EXPRESSION; GENE TRANSFER; HUMAN; KIDNEY; PRIORITY JOURNAL; SWINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL TRANSPORT; CYCLOSPORINE; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LLC-PK1 CELLS; P-GLYCOPROTEIN; SWINE; TRANSFECTION;

EID: 0030891179     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00810-6     Document Type: Article

References (19)

1. Roninson IB (Ed.), Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. Plenum Press, New York, 1991.
2. Gottesman MM and Pastan I, Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993.
3. Ganapathi R, Kuo T, Teeter L, Grabowski D and Ford J, Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug resistance. Mol Pharmacol 39: 1-8, 1991.
4. Choi K, Frommel TO, Stern RK, Perez CF, Kriegler M, Tsuruo T and Roninson IB, Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection. Proc Natl Acad Sci USA 88: 7386-7390, 1991.
5. Nielsen D, Maare C and Skovsgaard T, Kinetics of daunorubicin transport in Ehrlich ascites tumor cells with different expression of P-glycoprotein: Influence of verapamil. Biochem Pharmacol 47: 2125-2135, 1994.
6. Ishida Y, Shimada Y and Shmoyama M, Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug resistant cultured human leukemia cells. Jpn J Cancer Res 81: 834-841, 1990.
7. Hirai M, Tanaka K, Shimizu T, Tanigawara Y, Yasuhara M, Hori R, Kakehi Y, Yoshida O, Ueda K, Komano T and Inui K, Cepharathin, a multidrug resistant modifier, is a substrate for P-glycoprotein. J Pharmacol Exp Ther 275: 73-78, 1995.
8. Tanaka K, Hirai M, Tanigawara Y, Yasuhara M, Hori R, Ueda K and Inui K, Effect of cyclosporin analogues and FK506 on transcellular transport of daunorubicin and vinblastine via P-glycoprotein. Pharm Res 13: 1081-1085, 1996.
9. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T and Hori R, Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 267: 24248-24252, 1992.
10. Akiyama S, Fojo A, Hanover JA, Pastan I and Gottesman MM, Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Mol Genet 11: 117-126, 1985.
11. Carmichael J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB, Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987.
12. Cornwell MM, Gottesman MM and Pastan I, Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells. J Biol Chem 261: 7921-7928, 1986.
13. Saeki T, Ueda K, Tanigawara Y, Hori R and Komano T, Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem 268: 6077-6080, 1993.
14. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai S-L, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM and Pastan I, Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81: 116-124, 1989.
15. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD and Roninson IB, Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160-7164, 1990.
16. Nooter K and Herweijer H, Multidrug resistance (mdr) genes in human cancer. Br J Cancer 63: 663-669, 1991.
17. Goldstein L, Clinical reversal of drug resistance. Curr Probl Cancer 19: 67-124, 1995.
18. Kohno K, Sato S, Takano H, Matsuo K and Kuwano M, The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem Biophys Res Commun 165: 1415-1421, 1989.
19. Kane SE, Reinhard DH, Fordis CM, Pastan I and Gottesman MM, A new vector using the multidrug resistance gene as a selective marker enables overexpression of foreign genes in eukaryotic cells. Gene 84: 439-446, 1989.